Missense mutations of the BRAF gene in human lung adenocarcinoma - PubMed (original) (raw)

. 2002 Dec 1;62(23):7001-3.

Affiliations

• PMID: 12460919

Missense mutations of the BRAF gene in human lung adenocarcinoma

Katsuhiko Naoki et al. Cancer Res. 2002.

Abstract

Mutations of the BRAF protein serine/threonine kinase gene have recently been identified in a variety of human cancers, most notably melanomas. We sought to determine the frequency of BRAF mutations in human lung cancer pathogenesis. Analysis of BRAF sequence from 127 primary human lung adenocarcinomas revealed mutations in two tumor specimens, one in exon 11 (G465V), and a second in exon 15 (L596R). These specimens belong to the same adenocarcinoma subgroup as defined by clustering of gene expression data. BRAF may provide a target for anticancer chemotherapy in a subset of lung adenocarcinoma patients.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • H1 Connect - Access expert opinions and insights on biomedical research.
  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc
  • GlyGen glycoinformatics resource

• Research Materials

  • NCI CPTC Antibody Characterization Program